Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryApr082015	Fate Therapeutics to Present at 14th Annual Needham Healthcare Conference SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases, today announced that Christian Weyer, M.D., M.A.S., President and Read All »	View HTML Fate Therapeutics to Present at 14th Annual Needham Healthcare Conference 10.5 KB
Toggle SummaryFeb072013	Fate Therapeutics to Present at 15th Annual BIO CEO & Investor Conference SAN DIEGO, Feb. 7, 2013 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc., a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators, today announced that Christian Weyer, M.D., M.A.S., President and Chief Executive Officer, will be presenting a company overview Read All »	View HTML Fate Therapeutics to Present at 15th Annual BIO CEO & Investor Conference 9.8 KB
Toggle SummaryAug292019	Fate Therapeutics to Present at 2019 Wells Fargo Healthcare Conference SAN DIEGO , Aug. 29, 2019 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that Scott Wolchko , President and Chief Executive Read All »	View HTML
Toggle SummaryApr032024	Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference SAN DIEGO , April 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to Read All »	View HTML
Toggle SummaryJan062015	Fate Therapeutics to Present at Biotech Showcase 2015 SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases, today announced that Christian Weyer, M.D., M.A.S., President and Read All »	View HTML Fate Therapeutics to Present at Biotech Showcase 2015 10.6 KB
Toggle SummaryJan062016	Fate Therapeutics to Present at Biotech Showcase 2016 SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders, announced today that Scott Wolchko, President and Chief Executive Read All »	View HTML Fate Therapeutics to Present at Biotech Showcase 2016 10.8 KB
Toggle SummaryFeb252013	Fate Therapeutics to Present at Cowen & Co. 33rd Annual Health Care Conference Fate Therapeutics to Present at Cowen & Co. 33rd Annual Health Care Conference San Diego, CA – Fate Therapeutics, Inc., a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators, announced today that Christian Weyer, M.D., M.A.S., President Read All »	View HTML Fate Therapeutics to Present at Cowen & Co. 33rd Annual Health Care Conference 10 KB
Toggle SummaryFeb252015	Fate Therapeutics to Present at Cowen & Company 35th Annual Health Care Conference SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases, today announced that Christian Weyer, M.D., M.A.S., President and Read All »	View HTML Fate Therapeutics to Present at Cowen & Company 35th Annual Health Care Conference 10.5 KB
Toggle SummaryApr302014	Fate Therapeutics to Present at Deutsche Bank 39th Annual Health Care Conference SAN DIEGO, April 30, 2014 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that Christian Weyer, M.D., M.A.S., President and Chief Executive Read All »	View HTML Fate Therapeutics to Present at Deutsche Bank 39th Annual Health Care Conference 10.3 KB
Toggle SummaryApr292015	Fate Therapeutics to Present at Deutsche Bank 40th Annual Health Care Conference SAN DIEGO, April 29, 2015 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases, today announced that Christian Weyer, M.D., M.A.S., President and Read All »	View HTML Fate Therapeutics to Present at Deutsche Bank 40th Annual Health Care Conference 10.5 KB

DISCLOSURE NOTICE: The information contained in each press release is as of the date of the respective press release. The Company assumes no obligation to update any information or forward-looking statement contained in any press release as a result of new information or events or developments arising after the date of such press release.